Forbion Growth Management B.V., 10% Owner: enGene Therapeutics ENGN Buy · Filed 24/10/18

Trade details

Type: Insider buy
Amount: $2,164,044.88
Shares · price: 341,332 sh · $6.34 a share
Held after: 2,400,791 sh
Stock: enGene Therapeutics ENGN
Person: Forbion Growth Management B.V.10% Owner
Trade date: 24/09/30
Filed: 24/10/18
Days to filing: 18 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +16.6%

enGene Therapeutics trades, last 26 weeks

What else happened in enGene Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/31~24/10/30

Forbion Growth Management B.V.'s recent trades

Forbion Growth Management B.V.10% Owner
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$762.3K
29,846 sh
$762.3K
Filed 25/01/02
Traded 24/12/30
Forbion Growth Management B.V.10% Owner
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$1.1M
41,472 sh
$1.1M
Filed 24/12/30
Traded 24/12/27
Forbion Growth Management B.V.10% Owner
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$869.7K
33,438 sh
$869.7K
Filed 24/12/30
Traded 24/12/26
Forbion Growth Management B.V.10% Owner
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$1.1M
44,143 sh
$1.1M
Filed 24/12/26
Traded 24/12/20
Forbion Growth Management B.V.10% Owner
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$640.6K
25,132 sh
$640.6K
Filed 24/12/26
Traded 24/12/23